Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes roger pls enlighten us , you have lost a complete fortune and only now have decided to do some research , I believe STUPID HAS BEEN GIVEN A WHOLE NEW MEANING BY YOU ....
THE TRUTH IS YOU SEEKING TO MISLEAD US ALL , Hopping we sell out now , so you get in for even cheaper than it is now , and level up and make a huge profit on friday ...
grow up you silly person .. you have bee caught out lo,l
Ell if you're in here too Metac.nt you'll be losing too very soon. Seems like I'm not the only one who didn't read the report...
I am just LMAO at Rodger the Rabbits latest posts..
He's apparently lost a fortune on GDR? But apparently recently 'bought back in' only to discover he didn't do his DD and now faces losing even more!!!
Tiger, you utter jerk. It’s a public consultation…. Find it on NICE website. You can see every comment made and then the response from the NICE panel. Nothing is hidden and not classified you idiot. Actually read it rather than just saying I’ve read it.
I think Gino was being disingenuous when he said he could see no reason why it wouldn’t granted Full recommendation. When I watched that presentation again the other day the person I was least convinced by was the CFO, who seemed reluctant to say anything and was clearly uncomfortable all the way through it
Excellent post JIMY boy... now would the full recommendation come out first thing on friday from NICE , or would the rocket be launched after hours on friday , so they can open on Monday with a re - rate .. OMG fasten your seat belts ... this is so exciting ...
Roger, regarding "final say"...
NHS have 3 months to allocate funding...
"Funding technology appraisal guidance
The Secretary of State has directed that the NHS is required to provide funding and resources for medicines and treatments recommended by NICE through its technology appraisals work programme. It normally has three months from the date of publication of each technology appraisal guidance to provide funding and resources.
Where it is not possible to acquire the technology or where, perhaps because insufficient trained staff are available, the intervention cannot be applied within the three month period, it can be extended. Extensions are granted by the Secretary of State, on advice from NICE.
The three month funding Direction has been waived or extended for about ten percent of the technology appraisals issued to date. They include surgery to aid weight reduction for people with morbid obesity, home compared with hospital haemodialysis for patients with end-stage renal failure, patienteducation models for diabetes, continuous subcutaneous insulin infusion for diabetes (insulin pumps) and photodynamic therapy for age-related macular degeneration."
The Genedrive POC test is to be used when lab testing isn't available (currently lab testing capacity too low) and in some cases not quick enough.
The Mantara lab test uses a lab in Germany. It's highly unlikely they pose any threat to the Genedrive test for NHS use.
Roger would you mind sharing this classified information with us please .
To clarify I have also read the NICE report , and we do not have any direct comp with any other bio tech , we are the first P O C and if you care to research correctly than you will find once NICE make a draft acceptance for a product , only 1 percent in the history of NICE dont get full approval ... its already approved and the NHS will take it on for use while the other tests are still at the early stages ...
No, I know, but they are clearly anti
And just found this from NICE themselves -
This guidance is advisory and does not have a funding
mandate. NHS England may decide to consider
CYP2C19 genotype testing for inclusion in the National
Genomics Test Directory.
So even if they do approve use of CYP2C19 the NHS will still have the final say on if/where/when the test is used.
Roger, fear not! The Mantara test is not a POC test, it is not a direct competitor.
Inagene Diagnostics also very actively trying to sway opinion against using CYP2C19 suggesting it won't be cost effective long term as there will be newer tests arriving before long that can have much broader scope in what can be tested for.
Gulp....I've spent the last hour and a half reading the NICE consultation documents. I think CYP2C19 is highly unlikely to be given full recommendation. there are numerous other organisations who are clearly anti and suggesting there are better tests eg Mantara Health PGx DNA test which tests for 12 genes rather than just one that GDR test for on reaction to Clopidogrel, and also more cost effective treatments, mainly laboratory testing.
My mood just sank as i read more and more. I think Gino was not being entirely honest when he said in the presentation that he can see 'no reason' why Full recommendation would not be forthcoming. Blimey I've just read the whole thing and I can see there's a lot of opposition. Have to say I was also very disappointed by the lack of submitted evidence from GDR themselves. they only get involved on a handful of issues where as both Mantara and Genomadix are working hard to highlight all and any possible negatives by using the CYP2C19 test.
Flipping heck. I should have read this sooner but now I can see why the share price is going nowhere and yet the consultation period will end this Friday. Bugger Bugger Bugger. I will be amazed if GDR can survive now. If they can't get it to a point where even the NHS will use the test then no will want to buy GDR so there's not even a glimmer of hope that we might see a take over on the cheap. Apologies not to post more positive news. It's grim imv
We'll see on Friday, just sit back and wait.
Good luck!
Roger , many thanks for your thoughts of how you perceive me,,
Fatsen your seat belts .. when this si explodes it will boom ...
Tiger,
What about you’re intel 😂
'and this is not financial advise'
ADVICE ADVICE ADVICE This is not financial ADVICE.
I would not ADVISE anyone to take your posts seriously Tiger. You've posted RNSs due any second for the last couple of weeks and there has been nothing, so it's fair to say most would rightly consider your 'opinions' as utter made up sh.te.
Morning Roger
Could not agree more , I am hoping for the same outcome in he exact order you have posted ... I dont believe will we de list .. there is way to much potential here ... so lets think positive and manifest , picture 65 p in days to come ...
Dear Proffesor
Your someone that clearly spends many hours on the net as a keyboard warrior ...
If you read all my posts to date , I have clearly advised these are my opinions , and this is not financial advise ...
I have based my posts on my calculations , my calculations , what I think will happen with my experience in investing .
Many thanks
Ooh only 7 trades today. That's not good for this company right now. It should be rising a little by the day with NICE news due to be confirmed by the end of this week. Official publication is in July but the public consultation ends on April 26th I think and we will be able to see on the online NICE page what the decision has been. I can't believe this company stocl is going to shaft me yet again... surely not?!
I'm thinking and hoping that some positive news will come from NICE that will see the sp shoot up and then Cheek pounces on a placing at a big discount but....at a price similar to where we are currently. This I hope will be swiftly followed by an announcement of the new partner for the FDA application process.
Odd we were told in an RNS about Brighton Sussex hospital taking on AIHL but we've heard nothing about the two new ones Cheek mentioned in his recent presentation.
I really hope GDR doesn't end up being yet another AIM company that delists because it's so undervalued on the LSE. The UK investment markets are slowly but surely turning to sh.t. Wasn't Brexit a wonderful thing eh?! So much good has come of it and everything is just that little bit better. Oh no, hang on a mo....
Https://twitter.com/genedriveplc/status/1781253907504894037/photo/1
Tiger 😂😂😂
You seem to allude , that you have serious intel stating that a RNS will be sanctioned at a specific time, I guess based or some information.
You are now clarifying nobody knows barring the company.
Therefore you have been deliberately misleading people…
Who’s gonna knock first, - SFO or Karma!
Roger Many thanks for your post and opinions , which most of I agree with ..
My thoughts are that when a company has two devices days / weeks away from approvals , and already through the doors with in the NHS , the funding and partnerships will find there place ... hence I am excited and believe this will rocket when all is in place .
I believe its there time now ... I really do ...
No one knows whats really going on on the back ground ... or there plan ... all we do know is NICE will give full approvals shortly ... roll on monday ...
Sickly GDR still limping along!!!!!
Tiger, Cheek said they were finalising contracts and ready to sign back in the December presentation and led us to believe it was imminent. Nice news was at that stage a full seven or eight months off. Something has cropped up that’s stopped then signing on the dotted line. Maybe they wanted RF out. They are now. But still there is no signing on the dotted line. I think it’s the funding issue. GDR isn’t far off from going bust and that’s got to be Cheek’s biggest hope - that the sp starts to fly as we draw near to that hoped for full recommendation and he does a raise on the back of that, and then the FDA partner will sign.
Only problem is the sp won’t budge. It’s now not down to RF dumping shares, it’s purely that hardly anyone is buying. We’re in a chicken and egg situation. Everyone knows NICE news will land soon. Unfortunately everyone also knows so will a placing at what is likely to be a hefty discount.
Tiger, if you’ve put a lot of money in here then good luck. I’ve lost massively thus far and don’t trust any AIM management. When NICE news lands (assuming it’s good)& the placing is announced then I’ll get back in with more serious dosh. At the moment this amounts to a punt. One I’ve now got £22k in at 5.75p
Hope it goes the way you need it to.